Clinical study on safety assessment of PRP therapy for development dysplasia of hip(PRP for hip dysplasia) (PRP for hip dysplasia)
- Conditions
- Patients who is diagnosed Hip osteoarthritis (Kellgren and Lawrence grade 4) due to development dysp
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 5
1.Patients who have symptoms for more than 3 months
2.Patients who have continued pain even after taking NSAIDs for 6 week or more and who can not use NSAIDs for asthma and digestive tract ulcer
3. More than 20 years old
4. Other , patients who the doctor has determined that it is suitable for this clinical study
1.Patients with a history of hip surgery
2. Patients with abnormal platelet counts in peripheral blood
3.Person who smokes a lot (Brinkmanindex>600)
4. Treatment with anticoagulants(Warfarin)
5. Uncontrolled diabetes mellitus : HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration
6. Patients with malignancy
7. Patients less than 6 months after onset of cardiac infarction or cerebral infarction
8. Predictive survival period is less
than 1 year
9. Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis)
10.Dialysis patients
11. Compromised host
12.Requiring continued use of oral corticosteroid therapy
13. Less than 20 years old
14.Doctor has determined that it is not suitable for this clinical study
Study & Design
- Study Type
- Interventional
- Study Design
- single assignment
- Primary Outcome Measures
Name Time Method - safety
- Secondary Outcome Measures
Name Time Method